NCT06546202

Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China

Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China: A Retrospective, Database, Multi-center Study (ReTARdant)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,271 (actual)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to investigate the pharmacological treatment pattern among patients with diabetic peripheral neuropathic pain (DPNP) and chemotherapy-induced peripheral neuropathy (CIPN) in China.

Detailed description

Diabetic peripheral neuropathic pain (DPNP) and chemotherapy-induced peripheral neuropathy (CIPN) are common subtypes of neuropathic pain. The treatment pattern, subsequent medication usage, and adherence information of medication among these patients are still not clear. There is also an unmet need for the use of relevant analgesic medications in this area. This real-world data study aims to understand patients' characteristics, clinical diagnosis and treatment patterns, medication adherence, real-world effectiveness among DPNP and CIPN patients in China and will explore the current unmet needs of DPNP and CIPN, in order to inform physicians' decision-making in clinical practice

Conditions

• Diabetic Peripheral Neuropathic Pain
• Chemotherapy-induced Peripheral Neuropathy
• Neuropathic Pain

Interventions

Type	Name	Description
OTHER	No Drug	This is an non-interventional, observational study. No drug was administered during this study.

Timeline

• Start date: 2024-08-16
• Primary completion: 2025-07-18
• Completion: 2025-07-18
• First posted: 2024-08-09
• Last updated: 2025-07-23

Locations

10 sites across 1 country: China